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1. INTRODUCTION {#ags312058-sec-0001}
===============

Recently, focus has been on metabolome analysis as a method of post‐genomic analysis. Metabolome analysis is one of the omics, which investigates the final product of a central dogma. Metabolome analysis is defined as the comprehensive analysis of small molecules (typically \<1.5 kDa) such as amino acids, organic acids, sugars, lipids, inorganic ions and so on.[1](#ags312058-bib-0001){ref-type="ref"} The number of human metabolites is estimated to range from 2500 to 8000.[2](#ags312058-bib-0002){ref-type="ref"}, [3](#ags312058-bib-0003){ref-type="ref"} Currently, three major analytical methods have been widely used in metabolome analysis including gas chromatography/mass spectrometry (GC/MS), liquid chromatography‐mass spectrometry (LC‐MS) and capillary electrophoresis‐mass spectrometry (CE‐MS), and each method is able to analyze a different class of metabolites.[3](#ags312058-bib-0003){ref-type="ref"}, [4](#ags312058-bib-0004){ref-type="ref"}

It has been well established that the liver can regenerate after hepatectomy (Hx).[5](#ags312058-bib-0005){ref-type="ref"} The authors have previously reported that liver regeneration is a fundamental mechanism by which the liver responds to various injuries such as ischemia reperfusion (I/R) injury.[6](#ags312058-bib-0006){ref-type="ref"}, [7](#ags312058-bib-0007){ref-type="ref"}, [8](#ags312058-bib-0008){ref-type="ref"} Although the molecular and cellular mechanism of liver regeneration after Hx is well understood, postoperative liver failure after Hx is still one of the critical problems in clinical settings.

There have been no reports about liver metabolites during liver regeneration using metabolome analysis. It was hypothesized that some key metabolites immediately after Hx could regulate or stimulate future liver regeneration. The aim of the present study was to investigate changes of liver metabolites following Hx with I/R towards liver regeneration using human Hx samples.

2. MATERIALS AND METHODS {#ags312058-sec-0002}
========================

2.1. Patients {#ags312058-sec-0003}
-------------

Twenty‐three patients who underwent Hx between April 2014 and March 2015 were enrolled in this study. Inclusion criteria for this study were: (i) primary Hx; (ii) \<15% of indocyanine green retention test (ICG R15); (iii) subsegmentectomy or more extended Hx; (iv) no biliary reconstruction and lymph node dissection; and (v) no preoperative chemotherapy. Backgrounds of the patients are shown in Table [1](#ags312058-tbl-0001){ref-type="table-wrap"}. The study was approved by the Tokushima University Hospital Ethics Committee and the corresponding regulatory agencies and all the experiments were carried out in accordance with the approved guidelines. Meanwhile, all the patients involved in the study signed the informed consent form and agreed to participate (To CMS ID; 1815).

###### 

Backgrounds of 23 patients who underwent Hx between April 2014 and March 2015

  ---------------------------------------------- --------------------------------
  Gender                                         
  Male/Female                                    20/3
  Age y (range)                                  65 (36‐81)
  Hepatitis virus                                
  HBV/HCV/nBnC                                   7/7/9
  Primary disease                                
  HCC/CCC/CRLM/Others)                           19/1/1/2
  Operative procedures                           
  HrS/Hr1/Hr2                                    7/4/12
  Resected liver volume (%/total liver volume)   
  HrS/Hr1/Hr2                                    9 (6‐12)/23 (20‐28)/52 (44‐61)
  Operative time min (range)                     314 (223‐452)
  Ischemic time min (range)                      42 (25‐81)
  Blood loss mL (range)                          175 (40‐644)
  ---------------------------------------------- --------------------------------

CCC, cholangiocellular carcinoma; CRLM, colorectal liver metastases; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; HrS, hepatic subsegmentectomy; Hr1, hepatic segmentectomy; Hr2, hepatic lobectomy; Hx, hepatectomy; nBnC, non B non C hepatitis.
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2.2. Sample collection {#ags312058-sec-0004}
----------------------

Non‐tumor tissues were sampled immediately before and after Hx. The collected samples were quickly frozen at −80°C until sample preparation was completed.

2.3. Metabolome analysis {#ags312058-sec-0005}
------------------------

Frozen tissue (c.a. 40 mg) was added to methanol (500 μL) containing internal standards (20 μmol L^−1^ each of methionine sulfone and [d]{.smallcaps}‐camphor‐10‐sulfonic acid) and homogenized using a beads beater (TOMY Micro Smash MS‐100R; Tomy Digital Biology, Tokyo, Japan) at 3000 rpm for 60 seconds. Then, both chloroform (500 μL) and Milli‐Q water (200 μL) were added to the homogenate. The solution was thoroughly mixed, then centrifuged at 4600 *g* for 15 minutes at 4°C, and the aqueous fraction was centrifugally filtered through a 5‐kDa‐cut‐off ultra‐centrifugal filter unit (Ultrafree‐MC‐PLHCC‐HMT; Human Metabolome Technologies Inc., Tsuruoka, Japan) to remove proteins. The filtrate was dried using an evacuated centrifuge and dissolved in Milli‐Q water (50 μL) containing 200 μmol L^−1^ reference compounds (3‐aminopyrrolidine and trimesic acid) prior to CE‐MS analysis. CE‐MS‐based metabolomic profiling and data analysis were carried out essentially as described.[9](#ags312058-bib-0009){ref-type="ref"}, [10](#ags312058-bib-0010){ref-type="ref"}, [11](#ags312058-bib-0011){ref-type="ref"}, [12](#ags312058-bib-0012){ref-type="ref"}, [13](#ags312058-bib-0013){ref-type="ref"}

2.4. Definitions of clinical parameters {#ags312058-sec-0006}
---------------------------------------

Preoperative, postoperative and changes between pre‐ and postoperative valine and tryptophan were compared in terms of the following clinical parameters (resected liver volume, regeneration rate, ischemic time, FIB‐4 index, and sarcopenia).

Resected liver volume: subsegmentectomy was grouped for the minor Hx group, and segmentectomy and lobectomy were grouped for the major Hx group.Regeneration rate: liver volumes before Hx and 1 week after Hx were measured using a 3D simulation imaging system. Regeneration rate was defined as the volume increase of the remnant liver as compared with the preoperative volume. Calculations were made using the following equation: regeneration rate = (\[postoperative liver volume\] − \[preoperative liver volume\]/\[preoperative liver volume\]) × 100 (%). The regeneration rate was divided into low and high regeneration groups by median value.Ischemic time: the cut‐off value of Pringle time was set at 30 minutes.FIB‐4 index: the cut‐off index value was set at 1.50.Sarcopenia: this was defined as both low grip strength and low muscular mass.

Low grip strength was defined as \<26 kg, male or \<18 kg, female.[14](#ags312058-bib-0014){ref-type="ref"} Muscular mass was examined with InBody 770^®^ (Kotoku, Tokyo, Japan). Low muscular mass was defined as \<90% of the standard (ranges from 90% to 110% of the standard) obtained by the InBody 770^®^.[15](#ags312058-bib-0015){ref-type="ref"}

2.5. Statistical analysis {#ags312058-sec-0007}
-------------------------

All data are expressed as median (range). Statistical analysis was carried out using Prism 6.07 for Windows (GraphPad Software Inc., La Jolla, CA, USA). *P*‐values \<.05 were considered to indicate statistically significant differences. Values between before and after Hx were compared using the Wilcoxon matched‐pairs signed‐rank test. Heat maps of metabolite levels were generated using hierarchical clustering based on Pearson correlation coefficients using the MultiExperiment Viewer (MeV) software (Institute for Genomic Research, Rockville, MD, USA). The data were exported and analyzed by principal components analysis (PCA) using SIMCA‐P software 12.0.1 (Umetrics AB, Umea, Sweden) to visualize the metabolic changes between preoperative and postoperative patients after mean centering and unit variance scaling.

3. RESULTS {#ags312058-sec-0008}
==========

3.1. Metabolic map {#ags312058-sec-0009}
------------------

In the pentose phosphate pathway, there were no significant differences between before and after Hx (Figure [1](#ags312058-fig-0001){ref-type="fig"}A). The metabolic pathway showed that there was a significant increase in "lactate" after Hx. There was only a significant decrease in metabolites in the first half of the TCA cycle, and adenosine triphosphate (ATP) by anaerobiotic glycolysis did not occur in time for energy consumption of the Hx (Figure [1](#ags312058-fig-0001){ref-type="fig"}B). This suggested that lipid metabolism might be more dominant than glucose metabolism after Hx.

![Metabolic map during liver regeneration. A, Pentose phosphate pathway; there were no significant differences between before and after hepatectomy (Hx). B, Glycolysis/tricarboxylic acid cycle (TCA) cycle; there was significant decrease only in metabolites in the first half of the TCA cycle, and ATP by anaerobiotic glycolysis did not occur in time for energy consumption of Hx. N.D., not detected](AGS3-2-204-g001){#ags312058-fig-0001}

3.2. Principal components analysis {#ags312058-sec-0010}
----------------------------------

Principal components analysis showed remarkably different component profiles between before and after Hx (Figure [2](#ags312058-fig-0002){ref-type="fig"}A). Out of a total of 267 metabolites, 103 metabolites that had a variable importance for projection (VIP) score of more than 1.0 were selected as critical metabolites for separating components (Figure [2](#ags312058-fig-0002){ref-type="fig"}B). Table [2](#ags312058-tbl-0002){ref-type="table-wrap"} shows all metabolites (VIP score \>1.0) and Figure [2](#ags312058-fig-0002){ref-type="fig"}C shows hierarchical clustering of 103 metabolites. Valine (VIP score: 1.78957) and tryptophan (VIP score: 1.74943) were significantly up‐regulated after Hx.

![A, Principal components analysis (PCA); PCA shows remarkably different components between before and after hepatectomy (Hx). B, Key 103 metabolites (VIP \>1.0); 103 metabolites in a total of 267 metabolites that had a VIP score of more than 1.0 were selected as critical metabolites for separating components. C, Hierarchical clustering. VIP, variable importance for projection](AGS3-2-204-g002){#ags312058-fig-0002}

###### 

Metabolites for separating components (VIP \>1.0)

       Metabolites                         VIP score         Metabolites                                 VIP score
  ---- ----------------------------------- ----------- ----- ------------------------------------------- -----------
  1    Lactate                             1.97604     53    UTP                                         1.4773
  2    CDP                                 1.96398     54    1‐Methyladenosine                           1.46181
  3    NADPH                               1.94671     55    *O*‐Phosphoserine                           1.45222
  4    Tyr                                 1.91601     56    1‐Methylnicotinamide                        1.44062
  5    UDP‐glucose                         1.86349     57    Met                                         1.4312
  6    Ala                                 1.85245     58    2‐Hydroxybutyrate                           1.41113
  7    ADP                                 1.8519      59    cis‐Aconitate                               1.39913
  8    GTP                                 1.82565     60    g‐Glu‐Ile                                   1.39354
  9    GDP                                 1.82553     61    Cys                                         1.38865
  10   CTP                                 1.82183     62    *N*‐Acetylglucosamine                       1.37152
  11   Leu                                 1.8197      63    Inosine                                     1.36748
  12   Choline                             1.81496     64    Carnitine                                   1.36734
  13   Succinate                           1.80697     65    Gluconate                                   1.35793
  14   ATP                                 1.80538     66    2,3‐DPG                                     1.34099
  15   beta‐Ala                            1.80077     67    Glutathione(ox)                             1.33471
  16   Urate                               1.79285     68    2PG                                         1.33419
  17   Val                                 1.78957     69    g‐Glu‐Arg                                   1.3306
  18   Homovanillate                       1.78688     70    Uridine                                     1.29395
  19   gamma‐Glu‐cys                       1.78348     71    g‐Glu‐Ala                                   1.29336
  20   Citrate                             1.78155     72    5‐Hydroxylysine                             1.29306
  21   Ile                                 1.77265     73    g‐Glu‐Gly‐Gly                               1.28145
  22   Pro                                 1.76593     74    2‐Hydroxyglutarate                          1.25326
  23   Phe                                 1.76262     75    ADP‐glucose                                 1.24392
  24   Xanthine                            1.75003     76    IMP                                         1.2395
  25   Trp                                 1.74943     77    F1,6P                                       1.2363
  26   Gly                                 1.74604     78    Creatinine                                  1.21506
  27   Adenosine 3′,5′‐diphosphate         1.7337      79    CMP‐*N*‐acetylneuraminate                   1.21174
  28   Kynurenine                          1.71002     80    g‐Glu‐Trp                                   1.20549
  29   UDP‐glucuronate                     1.69116     81    Sarcosine                                   1.2001
  30   CMP                                 1.67643     82    Fumarate                                    1.19877
  31   Uracil                              1.66857     83    4‐Methyl‐2‐oxopentanoate                    1.19797
  32   *o*‐Acetylcarnitine                 1.66437     84    Ru5P                                        1.17545
  33   Thiamine                            1.66161     85    Mucate                                      1.16441
  34   Glycerophosphate                    1.6597      86    *N*‐Acetylhistidine                         1.16288
  35   *N*‐Acetylglucosamine 6‐phosphate   1.63273     87    g‐Glu‐Phe                                   1.1496
  36   Isocitrate                          1.62491     88    g‐Glu‐Leu                                   1.13668
  37   Glucose                             1.62172     89    g‐Glu‐Val                                   1.13623
  38   4‐Oxopentanoate                     1.60649     90    Gly‐Leu                                     1.11075
  39   Hypoxanthine                        1.6039      91    *N*,*N*‐Dimethylglycine                     1.10164
  40   Nicotinamide                        1.59889     92    g‐Glu‐His                                   1.09598
  41   Xanthosine                          1.59198     93    Cysteine‐glutathione disulfide ‐ divalent   1.09562
  42   *N*‐Acetylglucosamine 1‐phosphate   1.58238     94    Ophthalmate                                 1.08533
  43   Lys                                 1.55611     95    *N*‐Acetylmethionine                        1.0849
  44   GABA                                1.5491      96    Pipecolate                                  1.08293
  45   cAMP                                1.54597     97    Pantothenate                                1.07741
  46   threo‐beta‐methylaspartate + Glu    1.53009     98    Putrescine (1,4‐butanediamine)              1.06563
  47   CDP‐choline                         1.52931     99    g‐Glu‐Gln                                   1.0381
  48   Cystathionine                       1.52375     100   *N*‐epsilon‐acetyllysine                    1.03715
  49   *N*1‐Acetylspermidine               1.50057     101   Glu                                         1.03233
  50   Glucosamine                         1.48626     102   *N*8‐Acetylspermidine                       1.01626
  51   3PG                                 1.48145     103   UDP                                         1.00423
  52   Asn                                 1.48075                                                       

VIP, variable importance for projection.
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3.3. Valine/tryptophan and clinical parameters {#ags312058-sec-0011}
----------------------------------------------

In the case of valine, much more resected volume and longer ischemic time affected its up‐regulation. Furthermore, preoperative valine significantly increased in the high FIB‐4 group whereas sarcopenia did not affect valine expression. Tryptophan was found to have similar tendencies to valine (Table [3](#ags312058-tbl-0003){ref-type="table-wrap"}).

###### 

Valine/tryptophan and clinical parameters

                  Grouping                         Valine                           *P*‐value
  --------------- -------------------------------- -------------------------------- ------------
  Resected LV                                                                       
  Post/Pre        HrS vs Hr1 or Hr2                1.9 (1.2‐2.3) vs 2.4 (1.4‐4.1)   *P* \< .01
  Liver RR        Cut‐off; median                                                   
  Post/Pre        Low vs High                      2.4 (1.2‐2.7) vs 2.2 (1.4‐4.1)   *P* = .72
  Ischemic time   Cut‐off; 30 min                                                   
  Post/Pre        Short vs Long                    1.5 (1.2‐2.3) vs 2.3 (1.4‐4.1)   *P* = .08
  FIB‐4 index     Cut‐off; 1.50                                                     
  Pre             Low vs High                      199 (142‐307) vs 258 (187‐458)   *P* = .04
  Post            498 (374‐614) vs 568 (322‐927)   *P* = .21                        
  Post/Pre        2.3 (1.9‐3.3) vs 2.3 (1.2‐4.1)   *P* = .41                        
  Sarcopenia                                                                        
  Pre             Non‐Sarco. vs Sarco.             238 (142‐458) vs 277 (224‐291)   *P* = .99
  Post            571 (374‐927) vs 558 (322‐617)   *P* = .50                        
  Post/Pre        2.3 (1.2‐4.1) vs 1.9 (1.4‐2.2)   *P* = .22                        

HrS, hepatic subsegmentectomy; Hr1, hepatic segmentectomy; Hr2, hepatic lobectomy; LV, liver volume; RR, regeneration rate; Sarco., sarcopenia.
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4. DISCUSSION {#ags312058-sec-0012}
=============

In the present metabolomics study: (i) the metabolic pathway showed that lipid metabolism might be more dominant than glucose metabolism after Hx; (ii) liver metabolites changed remarkably between before and after Hx; and (iii) liver valine and tryptophan were remarkably increased after Hx and they were regulated by resected liver volume, ischemic time and liver function.

It has already been reported that remnant liver metabolism after Hx switches to a predominant utilization of fatty acid as an energy source from glucose.[16](#ags312058-bib-0016){ref-type="ref"}, [17](#ags312058-bib-0017){ref-type="ref"} Within 24 hours after Hx, the uptake of free fatty acids in the residual hepatocytes was increased in order to acquire energy, and hepatocytes accumulated triglyceride (TG).[18](#ags312058-bib-0018){ref-type="ref"}, [19](#ags312058-bib-0019){ref-type="ref"}, [20](#ags312058-bib-0020){ref-type="ref"} In the present study, glucose metabolism did not occur in time for energy consumption after Hx, and lipid metabolism might be dominant for producing ATP. These results were reasonable for previous reports.

Regarding liver metabolism during liver regeneration, there was a report on amino acid and glucose metabolism in the rat fulminant hepatic failure (FHF) model.[21](#ags312058-bib-0021){ref-type="ref"} In that model, a new isolated perfused liver system in combination with a mass‐balance model to generate a metabolic map was introduced. However, the number of metabolites was limited, and it was not a comprehensive analysis. Conversely, metabolome analysis is concerned with the comprehensive analysis of endogenous low‐molecular‐weight compounds in biological samples.

Valine, which is one of the branched‐chain amino acids (BCAA), has been reported to stimulate the proliferation of hepatocytes by a dose dependent method in vitro.[22](#ags312058-bib-0022){ref-type="ref"} Valine was also found to be most effective in vivo among three BCAA in the Hx model. Furthermore, valine was reported to increase serum free fatty acid, or liver triglyceride, and up‐regulated liver fatty acid became a source of ATP production.[22](#ags312058-bib-0022){ref-type="ref"} Valine, was also reported to have an antioxidative effect by down‐regulating tumor necrosis factor (TNF) and up‐regulating superoxide dismutase 2 (SOD2) towards human umbilical vein endothelial cells (HUVEC).[23](#ags312058-bib-0023){ref-type="ref"}

In contrast, tryptophan was the major source of serotonin production, and platelets were major carriers of serotonin in the blood. In thrombocytopenic mice, a serotonin agonist reconstituted liver proliferation after Hx.[24](#ags312058-bib-0024){ref-type="ref"} Tryptophan might stimulate liver regeneration after Hx by serotonin. Furthermore, tryptophan regulated reactive oxygen species (ROS) by inducing nuclear factor (erythroid‐derived 2)‐like 2 (NF‐E2‐related factor 2 or Nrf2) in primary hepatocyte culture.[25](#ags312058-bib-0025){ref-type="ref"} In our hierarchical clustering, valine and tryptophan significantly increased after Hx, and they were regulated by resected liver volume, ischemic time and liver function. Although further investigations are necessary, these phenomena might reflect the remnant liver\'s protective response for I/R injury.

It was already reported that the period immediately after Hx (0‐6 hours after Hx) was critical for future liver regeneration.[5](#ags312058-bib-0005){ref-type="ref"}, [6](#ags312058-bib-0006){ref-type="ref"} In the present study, liver tissues were sampled immediately after Hx, and we hypothesized that metabolites immediately after Hx would affect future liver regeneration. However, there was a limitation of this study regarding the time‐point after Hx, and several time‐points after Hx might be necessary.

In conclusion, the present study identified the changes of liver metabolites in Hx with I/R towards liver regeneration. Liver metabolites changed remarkably between before and after Hx. In particular, liver valine and tryptophan were increased after Hx.

DISCLOSURE {#ags312058-sec-0014}
==========

Conflicts of Interest: Authors declare no conflicts of interest for this article.

Ethical Approval: All procedures carried out in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent: Informed consent was obtained from all individual participants included in the study.

We thank Kaori Igarashi, Maki Ohishi, Keiko Kato, Daisuke Kajiura and Hiroshi Tatano (for metabolome analysis) for their support in the present study.
